SLLK, Control Peptide for TSP1 Inhibitor

Modify Date: 2024-01-08 23:28:40

SLLK, Control Peptide for TSP1 Inhibitor structure	Common Name	SLLK, Control Peptide for TSP1 Inhibitor
	CAS Number	464924-27-4	Molecular Weight	459.580
	Density	1.3±0.1 g/cm3	Boiling Point	690.1±65.0 °C at 760 mmHg
	Molecular Formula	C₂₁H₄₁N₅O₆	Melting Point	N/A
	MSDS	N/A	Flash Point	371.2±34.3 °C

Use of SLLK, Control Peptide for TSP1 Inhibitor

SLLK, Control Peptide for TSP1 Inhibitor is a control peptide for LSKL (leucine-serine-lysine-leucine).

Name	(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-1,3-dihydroxy-propylidene]amino]-1-hydroxy-4-methyl-pentylidene]amino]-1-hydroxy-4-methyl-pentylidene]amino]hexanoic acid

Description	SLLK, Control Peptide for TSP1 Inhibitor is a control peptide for LSKL (leucine-serine-lysine-leucine).
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Cancer Peptides
In Vivo	TGF-β1 is significantly lower (0.10±0.01 pg/mL) in the plasma of mice receiving LSKL compared with that in plasma of mice receiving SLLK control peptide at day 42 (0.20±0.02 pg/mL; P=0.0001). mRNA expression is assessed in the suprarenal aortic lysates obtained from mice receiving SLLK and LSKL peptides[1]. Akita mice treated with 30 mg/kg LSKL have significantly increased nephrin expression, greater than twofold, compared with renal lysates from either saline controls or SLLK-treated mice[2].
Animal Admin	Sterile solutions of LSKL or SLLK peptide are made in stock solutions of 3.0 mg/mL (high dose) or 0.3 mg/mL (low dose) in sterile saline. The i.p. injection of LSKL, SLLK, or saline began 2 weeks after uninephrectomy and continues thrice weekly for 15 weeks. For the low-dosage treatment regimen, each group of 20 mice receives 3 mg/kg body weight of peptide (LSKL or SLLK) per injection or saline (100 μL/10 g body weight per injection). For the high-dosage treatment regimen, Akita mice ae given i.p. injections of LSKL or SLLK peptide at 30 mg/kg body weight per injection or saline (100 μL/10 g body weight per injection).
References	[1]. Krishna SM, et al. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):389-98. [2]. Lu A, et al. Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am J Pathol. 2011 Jun;178(6):2573-86.

Density	1.3±0.1 g/cm3
Boiling Point	690.1±65.0 °C at 760 mmHg
Molecular Formula	C₂₁H₄₁N₅O₆
Molecular Weight	459.580
Flash Point	371.2±34.3 °C
Exact Mass	459.305695
LogP	2.91
Vapour Pressure	0.0±4.9 mmHg at 25°C
Index of Refraction	1.565
Storage condition	2-8℃

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: SLLK, Control Peptide for TSP1 Inhibitor?
Price: Click To Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com

DC Chemicals Limited
China
Product Name: SLLK, Control Peptide for TSP1 Inhibitor(TFA)
Price: ￥850.0/100mg ￥1700.0/250mg ￥3400.0/1g
Purity: 98.0%
Delivery: 10 Day
Contact: Tony Cao
Email: sales@dcchemicals.com

Taiwan Oyi peptide Co. Ltd
China
Product Name: SLLK, Control Peptide for TSP1 Inhibitor
Price: $Inquiry/1mg $Inquiry/100kg
Purity: 98.0%
Delivery: 1 Day
Contact: Vinnie
Email: Jamie@api-made.com

Get all suppliers and price by the below link:

SLLK, Control Peptide for TSP1 Inhibitor suppliers

Price: ￥900/1 mg

Reference only. check more SLLK, Control Peptide for TSP1 Inhibitor price